OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
An update on the pathophysiology of immune thrombocytopenia	79
ANGPTL4: a multifunctional protein involved in metabolism and vascular homeostasis	73
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	44
Structural organization of the bone marrow and its role in hematopoiesis	35
Effective use of hydroxyurea for sickle cell anemia in low-resource countries	34
The rebirth of the contact pathway: a new therapeutic target	31
Brothers in arms: platelets and neutrophils in ischemic stroke	29
Mechanisms of immunothrombosis in COVID-19	29
Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease	29
The many flavors of monocyte/macrophage--endothelial cell interactions	28
Protection of hematopoietic stem cells from stress-induced exhaustion and aging	28
Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia	26
Advances in chimeric antigen receptor T cells	23
Human babesiosis: recent advances and future challenges	22
The interaction between the complement system and hemostatic factors	21
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases	20
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes	17
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms	17
Single-cell fate decisions of bipotential hematopoietic progenitors	16
Update on the pathophysiology of transfusion-related acute lung injury	16
Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology	16
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	15
Germline mutations in MDS/AML predisposition disorders	15
Hematopoietic stem cell regulation by the proteostasis network	15
Genetic heterogeneity and clonal evolution in acute myeloid leukemia	14

The Nlrp3 inflammasome – the evolving story of its positive and negative effects on hematopoiesis	14
Small molecule therapeutics to treat the β-globinopathies	13
Vascular elastic fiber heterogeneity in health and disease	13
Role of complement in alloimmunization and hyperhemolysis	13
Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants	12
Recent advances in factor XII structure and function	12
The N6-methyladenosine RNA modification in acute myeloid leukemia	12
Systems analysis of hematopoiesis using single-cell lineage tracing	12
When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies	11
GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine	11
An expanded role for dipeptidyl peptidase 4 in cell regulation	11
Human hematopoiesis: aging and leukemogenic risk	11
Symmetric and asymmetric activation of hematopoietic stem cells	11
Ineffective erythropoiesis in sickle cell disease: new insights and future implications	10
Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and management	10
Prothrombotic state associated with preeclampsia	10
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia	10
The congenital dyserythropoieitic anemias: genetics and pathophysiology	10
Mouse models of vascular development and disease	10
Protein S: function, regulation, and clinical perspectives	9
The protein C pathways	9
Cellular components of the hematopoietic niche and their regulation of hematopoietic stem cell function	9
Current and future gene therapies for hemoglobinopathies	9
Casting a NET on cancer: the multiple roles for neutrophil extracellular traps in cancer	8
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	8
Regulation and importance of factor VIII levels in hemophilia A carriers	8
Translational control by heme-regulated elF2α kinase during erythropoiesis	8
Complement contributions to COVID-19	8
Blood in the water: recent uses of zebrafish to study myeloid biology	8
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	8
Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications	7
Regulation of stress-induced hematopoiesis	7
A zebrafish toolbox for biomechanical signaling in cardiovascular development and disease	7
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	7
Immunomodulatory roles of red blood cells	7